5/14/2008 8:27:30 AM
GERMANTOWN, Wis.--(BUSINESS WIRE)--Cambridge Major Laboratories today announced a major expansion into large scale Active Pharmaceutical Ingredient (API) manufacturing. On June 5, 2008 the company will be breaking ground on a new 120,000 square foot, state-of-the-art API manufacturing site next to its headquarters in Germantown, Wisconsin USA. The facility is designed with multiple GMP manufacturing suites capable of producing multi-ton quantities of API, and is in response to the company’s large and growing pipeline of late developmental and commercial API’s. Completion is scheduled for August of 2009.
comments powered by